J Physiol Boston Smyposia
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 570, Number 2, 283-294, January 15, 2006 DOI: 10.1113/jphysiol.2005.100032
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
570/2/283    most recent
jphysiol.2005.100032v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Payne, A. M.
Right arrow Articles by Delbono, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Payne, A. M.
Right arrow Articles by Delbono, O.
Related Collections
Right arrow Cellular

CELLULAR

Motor neurone targeting of IGF-1 prevents specific force decline in ageing mouse muscle

Anthony M. Payne1, Zhenlin Zheng1, María Laura Messi1, Carol E. Milligan2, Estela González1 and Osvaldo Delbono1,3,4

1 Department of Physiology and Pharmacology
2 Department of Neurobiology & Anatomy
3 Department of Internal Medicine, Section on Gerontology
4 Neuroscience Program, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA

IGF-1 is a potent growth factor for both motor neurones and skeletal muscle. Muscle IGF-1 is known to provide target-derived trophic effects on motor neurones. Therefore, IGF-1 overexpression in muscle is effective in delaying or preventing deleterious effects of ageing in both tissues. Since age-related decline in muscle function stems partly from motor neurone loss, a tetanus toxin fragment-C (TTC) fusion protein was created to target IGF-1 to motor neurones. IGF-1–TTC retains IGF-1 activity as indicated by [3H]thymidine incorporation into L6 myoblasts. Spinal cord motor neurones effectively bound and internalized the IGF-1–TTC in vitro. Similarly, IGF-1–TTC injected into skeletal muscles was taken up and retrogradely transported to the spinal cord in vivo, a process prevented by denervation of injected muscles. Three monthly IGF-1–TTC injections into muscles of ageing mice did not increase muscle weight or muscle fibre size, but significantly increased single fibre specific force over aged controls injected with saline, IGF-1, or TTC. None of the injections changed muscle fibre type composition, but neuromuscular junction post-terminals were larger and more complex in muscle fibres injected with IGF-1–TTC, compared to the other groups, suggesting preservation of muscle fibre innervation. This work demonstrates that induced overexpression of IGF-1 in spinal cord motor neurones of ageing mice prevents muscle fibre specific force decline, a hallmark of ageing skeletal muscle.

(Received 12 October 2005; accepted after revision 11 November 2005; first published online 17 November 2005)
Corresponding author O. Delbono: Department of Physiology and Pharmacology, Wake Forest University School of Medicine, 1 Medical Center Boulevard, Winston-Salem, NC 27157, USA. Email: odelbono{at}wfubmc.edu


A. M. Payne and Z. Zheng contributed equally to this work.




This article has been cited by other articles:


Home page
EndocrinologyHome page
K. A. Sullivan, B. Kim, and E. L. Feldman
Insulin-Like Growth Factors in the Peripheral Nervous System
Endocrinology, December 1, 2008; 149(12): 5963 - 5971.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
J. L. Carrington and F. L. Bellino
Developing a Research Agenda in Biogerontology: Physiological Systems
Sci. Aging Knowl. Environ., June 28, 2006; 2006(10): pe17 - pe17.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 The Physiological Society.